
ARTES Biotechnology GmbH Resources
Find the latest Resources from ARTES Biotechnology GmbH
Cell line development based on efficient high-yield microbial expression platforms
Monday 3rd July 2017
BioSimilars – Technology Transfer
Tuesday 23rd May 2017
METAVAX® – Proprietary Innovative Vaccine Platform
Wednesday 10th May 2017